169 related articles for article (PubMed ID: 38842841)
1. Radiation With Immunotherapy May Be a Double-Edged Sword-How Can We Learn From Recent Negative Clinical Trials?
McGee HM; Williams TM; Lee P
JAMA Oncol; 2024 Jun; ():. PubMed ID: 38842841
[TBL] [Abstract][Full Text] [Related]
2. Radiotherapy: Brightness and darkness in the era of immunotherapy.
Zhai D; An D; Wan C; Yang K
Transl Oncol; 2022 May; 19():101366. PubMed ID: 35219093
[TBL] [Abstract][Full Text] [Related]
3. A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy.
Wang X; Wang P; Zhao Z; Mao Q; Yu J; Li M
Ther Adv Med Oncol; 2020; 12():1758835920926822. PubMed ID: 32518598
[TBL] [Abstract][Full Text] [Related]
4. Targeting ferroptosis in pancreatic cancer: a double-edged sword.
Chen X; Kang R; Kroemer G; Tang D
Trends Cancer; 2021 Oct; 7(10):891-901. PubMed ID: 34023326
[TBL] [Abstract][Full Text] [Related]
5. 14-3-3sigma, the double-edged sword of human cancers.
Li Z; Liu JY; Zhang JT
Am J Transl Res; 2009 Jun; 1(4):326-40. PubMed ID: 19956445
[TBL] [Abstract][Full Text] [Related]
6. A 'Hybrid' Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy.
Ji H; Zhou Z
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884565
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy and epithelial ovarian cancer: a double-edged sword?
Ray-Coquard I; Lorusso D
Ann Oncol; 2017 May; 28(5):909-910. PubMed ID: 28379282
[No Abstract] [Full Text] [Related]
8. Immunogenic Cell Death and Elimination of Immunosuppressive Cells: A Double-Edged Sword of Chemotherapy.
Fumet JD; Limagne E; Thibaudin M; Ghiringhelli F
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32947882
[TBL] [Abstract][Full Text] [Related]
9. A double-edged sword of immunotherapy: new category of colitis mimicking inflammatory bowel disease.
Mahadea DS; Śledzińska E; Dobrowolska A; Krela-Kaźmierczak I; Eder P
Pol Arch Intern Med; 2020 Nov; 130(11):1003-1004. PubMed ID: 32804446
[No Abstract] [Full Text] [Related]
10. A Double-Edged Sword Role of Cytokines in Prostate Cancer Immunotherapy.
Mao C; Ding Y; Xu N
Front Oncol; 2021; 11():688489. PubMed ID: 34868907
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Toxic Effects of Cancer Immunotherapy Combinations-A Double-edged Sword.
Tang C; Jiang W; Yap TA
JAMA Oncol; 2018 Aug; 4(8):1116-1117. PubMed ID: 29327039
[No Abstract] [Full Text] [Related]
12. Phenylpropanoids in radioregulation: double edged sword.
Kim W; Seong KM; Youn B
Exp Mol Med; 2011 Jun; 43(6):323-33. PubMed ID: 21483230
[TBL] [Abstract][Full Text] [Related]
13. More immunosuppressive, more immunotherapy responsive? A double-edged sword of HBV-induced immune response in HCC.
Huang CH; Hsieh SY
Hepatology; 2023 Sep; 78(3):706-708. PubMed ID: 37013921
[No Abstract] [Full Text] [Related]
14. Gut microbiota - a double-edged sword in cancer immunotherapy.
Andrews MC; Vasanthakumar A
Trends Cancer; 2023 Jan; 9(1):3-5. PubMed ID: 36088249
[TBL] [Abstract][Full Text] [Related]
15. The Research Progress of PD-1/PD-L1 Inhibitors Enhancing Radiotherapy Efficacy.
Wen L; Tong F; Zhang R; Chen L; Huang Y; Dong X
Front Oncol; 2021; 11():799957. PubMed ID: 34956911
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors.
Wang J; Zhu N; Su X; Yang R
Cancer Lett; 2024 Feb; 582():216582. PubMed ID: 38065401
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy for Management of Thymic Epithelial Tumors: A Double-Edged Sword.
Ballman M; Zhao C; McAdams MJ; Rajan A
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565190
[TBL] [Abstract][Full Text] [Related]
18.
Garcia Garcia CJ; Abi Jaoude J; Taniguchi CM
Cancer Res; 2021 Jun; 81(12):3158-3159. PubMed ID: 34224375
[TBL] [Abstract][Full Text] [Related]
19. The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens.
Mahajan S; Schmidt MHH; Schumann U
Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046685
[TBL] [Abstract][Full Text] [Related]
20. Tertiary Lymphoid Structures in Cancer: The Double-Edged Sword Role in Antitumor Immunity and Potential Therapeutic Induction Strategies.
Kang W; Feng Z; Luo J; He Z; Liu J; Wu J; Rong P
Front Immunol; 2021; 12():689270. PubMed ID: 34394083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
